A 2025 JAMA Psychiatry clinical trial found that adults with alcohol use disorder taking weekly semaglutide experienced significant reductions in alcohol cravings and consumption compared to placebo (source)
Discuss dose adjustments of insulin or sulfonylureas with your healthcare team
Final Verdict MEDVi provides a simple, practical, and highly accessible path to medically supervised GLP-1 treatment
Hypoglycaemia represents one potential contributor, particularly when Rybelsus is used in combination with other glucose-lowering medications such as sulphonylureas or insulin
Our team will review your health history, evaluate your eligibility, and guide you toward the safest and most effective treatments for your unique situation
Cut the amount in half, wait five days, repeat